Amundi Cuts Stake in Doximity, Inc. (NASDAQ:DOCS)

Amundi cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 93.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 11,656 shares of the company’s stock after selling 172,971 shares during the quarter. Amundi’s holdings in Doximity were worth $641,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. KBC Group NV raised its position in shares of Doximity by 22.9% during the 3rd quarter. KBC Group NV now owns 3,296 shares of the company’s stock worth $144,000 after purchasing an additional 614 shares during the last quarter. Natixis Advisors LLC grew its stake in shares of Doximity by 43.5% in the 3rd quarter. Natixis Advisors LLC now owns 31,815 shares of the company’s stock valued at $1,386,000 after buying an additional 9,644 shares during the period. Thrivent Financial for Lutherans grew its stake in shares of Doximity by 5.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company’s stock valued at $1,350,000 after buying an additional 1,474 shares during the period. Prospera Private Wealth LLC purchased a new position in shares of Doximity during the 3rd quarter worth approximately $133,000. Finally, Commerce Bank purchased a new position in shares of Doximity during the 3rd quarter worth approximately $314,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 37.40% of the company’s stock.

Doximity Trading Up 0.2 %

Shares of DOCS stock opened at $62.84 on Friday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The firm’s fifty day simple moving average is $64.20 and its 200 day simple moving average is $53.21. The firm has a market capitalization of $11.73 billion, a P/E ratio of 62.84, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on DOCS shares. Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Canaccord Genuity Group boosted their price target on shares of Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research report on Friday, February 7th. Needham & Company LLC lifted their price objective on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 7th. JPMorgan Chase & Co. lifted their price objective on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research note on Thursday, November 21st. Finally, Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Doximity presently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.